Q Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2004-01-01
- Employees
- 10
- Market Cap
- -
- Website
- http://www.qthera.com
Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis
Phase 1
Recruiting
- Conditions
- Transverse Myelitis
- Interventions
- Biological: Q-Cells
- First Posted Date
- 2019-03-22
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- Q Therapeutics, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT03887273
- Locations
- 🇺🇸
UT Southwestern, Dallas, Texas, United States
Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS)
Phase 1
Not yet recruiting
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- Biological: Q-Cells
- First Posted Date
- 2015-06-23
- Last Posted Date
- 2023-08-21
- Lead Sponsor
- Q Therapeutics, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02478450
© Copyright 2025. All Rights Reserved by MedPath